In 2026, the smartest skincare and cosmetic choices focus on long-term skin health, collagen support, and realistic outcomes.
HINESVILLE, GA, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- In a beauty landscape crowded with trends, ...
CK0804 is a first in class, CXCR4hi Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over expressed in the bone marrow and ...
Pharmaceutical Technology on MSN
Cellenkos gains FDA orphan drug status for CK0804 to treat myelofibrosis
CK0804 is an allogeneic, off‑the‑shelf Treg cell therapy.
News Medical on MSN
Repurposed drug combination shows strong promise against liver fibrosis
The study shows that this drug pair works far better together than either agent alone, offering a realistic and potentially fast path toward a new antifibrotic therapy. Liver fibrosis is a silent yet ...
A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets –– Pivotal Phase 3 trials in ...
Normal tissue function depends on adequate supply of oxygen through blood vessels. Understanding how blood vessels form has become a principal, yet challenging, objective of the last decade.
Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets - - Pivotal Phase 3 trials in wet AMD on track for data readout beginning in mid-2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results